OKYO PHARMA LTD SP.ADR/65 (OK10) — Financial Flexibility Index
OKYO PHARMA LTD SP.ADR/65 (OK10) has a Financial Flexibility Index of -0.20x as of March 2025. Free cash flow of €-1.81 Million (operating CF €-1.81 Million minus capex €1.21K) represents 0% of total liabilities (€9.23 Million). Also explore OK10 net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
OKYO PHARMA LTD SP.ADR/65 Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for OKYO PHARMA LTD SP.ADR/65 across 4 annual periods. See debt-free asset ratio of OKYO PHARMA LTD SP.ADR/65 to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for OKYO PHARMA LTD SP.ADR/65 (2022–2025)
Year-by-year free cash flow to debt coverage for OKYO PHARMA LTD SP.ADR/65. For the full company profile including market capitalisation, see OK10 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.20x | €-1.81 Million | €-1.81 Million | €9.23 Million | ▲ +84.7% |
| 2024 | -1.28x | €-9.49 Million | €-9.49 Million | €7.42 Million | ▼ -20.7% |
| 2023 | -1.06x | €-7.69 Million | €-7.70 Million | €7.26 Million | ▲ +73.8% |
| 2022 | -4.04x | €-5.47 Million | €-5.47 Million | €1.35 Million | — |